• Sacubitril/valsartan use after STEMI improves outcomes, promotes vascular remodeling

    6 days ago - By Healio

    Early sacubitril/valsartan initiation following STEMI improved clinical outcomes and promoted vascular remodeling compared with ramipril use, researchers reported.
    “We believe that the value of sacubitril/valsartan needs to be explored not just in end-stage HF,” Ahmed Rezq, MD, PhD, faculty of medicine in the department of cardiology at Ain Shams University and Dar Al Fouad Hospital, Cairo, told Healio. “We believe that the early initiation of this drug would improve the long-term outcomes after MI.”
    The randomized, active-controlled, double-blind, two-center study
    Read more ...